Skip to main content
Douglas Arenberg, MD, Pulmonology, Ann Arbor, MI

Douglas A Arenberg MD

Critical Care Medicine, Thoracic Oncology


Professor of Medicine, Pulmonary & Critical Care Medicine

Join to view full profile
  • 1150 West Medical Center Dr.6220 MSRB III SPC 5642Ann Arbor, MI 48109

  • Phone+1 734-647-6477

  • Fax+1 844-857-3177

Dr. Arenberg is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Arenberg is a Pulmonary & Critical Care Physician affiliated with Michigan Medicine, & University of Michigan Medical School. He received his MD from University of Illinois College of Medicine in 1990. He specializes in lung cancer diagnosis, staging, prevention (tobacco dependence treatment) and early detection. He is an Associate Editor for the Journal CHEST.
  • Welcome to T-cubed (Tobacco Treatment Tips)

    Provider oriented information on assessing and treating tobacco dependence

Education & Training

  • University of Michigan
    University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1996
  • University of Michigan Medical Center
    University of Michigan Medical Center1993
  • University of Michigan
    University of MichiganResidency, Internal Medicine, 1993
  • University of Michigan
    University of MichiganInternship, Internal Medicine, 1990 - 1991
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1990

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1990 - 2029
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Clinical Excellence Society Department of Internal Medicine
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Nodule Volume Measurement: pushing the Pendulum  
    Arenberg, DA, Chest, 3/1/2014
  • Implementation of a Lung Cancer-Screening Program  
    Arenberg DA, Current Surgery Reports, 1/1/2013
  • IASLC CT Screening Workshop 2011: Expert Pulmonary Group International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report  
    Field JK , et al, J Thorac Oncol, 1/1/2012

Books/Book Chapters

Abstracts/Posters

  • Lung injury accelerates growth of lung cancer cells in an orthotopic model of lung cancer.
    Arenberg DA, Carskadon SL, Zhao L, American Thoracic Society, Toronto, Ontario, Canada, 5/1/2008
  • The tumor microenvironment modulates the angiogenic phenotype in lung cancer. Diversity and plasticity of the angiogenic switch in lung cancer.
    Arenberg DA, Carskadon SL, Zhao L, White ES McClelland MR, American Thoracic Society, San Diego, CA, 5/1/2007
  • Diversity and plasticity of the angiogenic switch in lung cancer.
    McClelland MR, Carskadon SL, Zhao L, White ES, Arenberg DA, American Thoracic Society, San Diego, CA, 5/1/2006

Lectures

  • Cellvizio Pulmonary Roundtable Discussion. Invited Speaker 
    12/1/2014
  • Emerging Science and Therapies in Lung Cancers 
    New York, NY - 11/1/2014
  • Key Components of a Lung Cancer Screening Program. Invited Speaker 
    Gratiot Hospital, Midland, MI - 11/1/2014

Press Mentions

  • The Shifting Sands of Lung Cancer Screening
    The Shifting Sands of Lung Cancer ScreeningJuly 18th, 2022
  • The Shifting Sands of Lung Cancer Screening
    The Shifting Sands of Lung Cancer ScreeningJuly 18th, 2022
  • The Shifting Sands of Lung Cancer Screening
    The Shifting Sands of Lung Cancer ScreeningJuly 18th, 2022

Grant Support

  • Promotion Of Angiogenesis In Lung Cancer By MIFNational Cancer Institute2002–2010
  • IP-10 As An Angiostatic Factor In Lung CancerNational Cancer Institute1997–2001

Committees

  • Board Member, American College of Chest Physicians Board of Regents 2019 - Present
  • Panel Member, NCCN Tobacco Cessation Guidelines Panel 2016 - Present
  • Member, IASLC Smoking Cessation and Tobacco Policy Committee 2014 - Present

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: